The status of glycemic control: A cross-sectional study of outpatients with type 2 diabetes mellitus across primary, secondary, and tertiary hospitals in the Jiangsu province of China
- PMID: 20685506
- DOI: 10.1016/j.clinthera.2010.05.002
The status of glycemic control: A cross-sectional study of outpatients with type 2 diabetes mellitus across primary, secondary, and tertiary hospitals in the Jiangsu province of China
Abstract
Objectives: The aims of the study were to determine the following: the status of glycemic control in patients with type 2 diabetes mellitus (DM) at primary, secondary, and tertiary hospitals in the Jiangsu province of China; and the factors associated with achieving glycemic targets.
Methods: This study, in which patients were enrolled from July 20 to 31, 2009, at 56 diabetes centers, used a multiple-stage, stratified sampling method to select a representative sample of the population with DM in Jiangsu. The sampling process was stratified by geographic and demographic regions, and by the outpatient numbers in the hospitals. A primary hospital was defined as a community medical institution that provided primary health services; a secondary hospital was a local medical institution that provided comprehensive health services; and a tertiary hospital was a regional medical institution that provided comprehensive and specialist health services. In primary hospitals, patients with DM were treated by general physicians; at secondary and tertiary hospitals, they were seen by specialists. Also, primary and tertiary hospitals treated patients in cities, whereas secondary hospitals treated patients from towns or rural areas. Patients with a medical history of type 2 DM for >6 months and registration at each diabetes center for > or = 6 months, and who were residents of Jiangsu province, were recruited. During the patient enrollment visit, information about DM complications and comorbidities, as well as DM management, was obtained by retrospectively reviewing medical records; basic patient data (eg, date of birth, sex, weight, height) were obtained by patient interview. Blood samples were collected for assessment of glycosylated hemoglobin (HbA1c) at a central laboratory.
Results: Of 3046 sampled subjects, the analysis was performed in 2966 subjects with complete data. The mean (SD) HbA1c value for analyzed patients was 7.2% (1.6%). The proportion of patients with tight glycemic control was 40.2% (1193/2966) when a threshold of HbA1c <6.5% was used, and 56.1% (1665/2966) when a threshold of HbA1c <7.0% was used. Compared with patients who had inadequate glycemic control, those with tight control were younger (P < 0.001), had shorter duration of DM (P < 0.001), had lower body mass index (BMI) (P = 0.005 for HbA1c <6.5% and P = 0.01 for HbA1c <7.0%), had more education (P < 0.001) and income (P = 0.003 for HbA1c <6.5% and P = 0.008 for HbA1c <7.0%), were more likely to monitor their glucose (P = NS for HbA1c <6.5% and P = 0.043 for HbA1c <7.0%) and attend DM education (P = 0.027 for HbA1c <6.5% and P = 0.002 for HbA1c <7.0%) at least once a month, and were more likely to receive oral antidiabetic drugs (OADs) (P < 0.001). Age, BMI, and DM duration did not differ significantly between hospital types. Compared with primary (36.2%) and secondary hospitals (36.5%), tertiary hospitals (42.2%) had more patients with HbA1c <6.5% (P = 0.043); tertiary hospitals also had more patients with once-monthly glucose self-monitoring (P = 0.001), patients with higher income (P < 0.001) and education (P < 0.001), and those who were more likely to use > or = 2 OADs or insulin with OADs (P < 0.001).
Conclusion: The overall status of glycemic control was unsatisfactory during the study period, although patients at tertiary hospitals appeared to have better control than those at primary or secondary hospitals.
Copyright 2010 Excerpta Medica Inc. All rights reserved.
Comment in
-
Patient-centered services: what could we be doing right?Clin Ther. 2010 May;32(5):962-4. doi: 10.1016/j.clinthera.2010.05.009. Clin Ther. 2010. PMID: 20685504 No abstract available.
Similar articles
-
Glycemic and non-glycemic targets in younger and older North Indian subjects with type 2 diabetes in a Tertiary care hospital: A 10 year's retrospective data analysis.Diabetes Metab Syndr. 2016 Jan-Mar;10(1 Suppl 1):S130-4. doi: 10.1016/j.dsx.2015.10.010. Epub 2015 Oct 30. Diabetes Metab Syndr. 2016. PMID: 26564028
-
Randomized, open-label, parallel-group evaluations of basal-bolus therapy versus insulin lispro premixed therapy in patients with type 2 diabetes mellitus failing to achieve control with starter insulin treatment and continuing oral antihyperglycemic drugs: a noninferiority intensification substudy of the DURABLE trial.Clin Ther. 2010 May;32(5):896-908. doi: 10.1016/j.clinthera.2010.05.001. Clin Ther. 2010. PMID: 20685497 Clinical Trial.
-
Inadequate Glycaemic Control and Therapeutic Management of Adults over 65 Years Old with Type 2 Diabetes Mellitus in Spain.J Nutr Health Aging. 2017;21(10):1365-1370. doi: 10.1007/s12603-017-0869-4. J Nutr Health Aging. 2017. PMID: 29188902
-
Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy.Clin Ther. 2007;29 Spec No:1236-53. Clin Ther. 2007. PMID: 18046925 Review.
-
Glycated Hemoglobin (HbA1c) Concentrations Among Children and Adolescents With Diabetes in Middle- and Low-Income Countries, 2010-2019: A Retrospective Chart Review and Systematic Review of Literature.Front Endocrinol (Lausanne). 2021 Apr 12;12:651589. doi: 10.3389/fendo.2021.651589. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33912137 Free PMC article.
Cited by
-
Successful Implementation and Development of a Phase II Cardiac Rehabilitation Program: A China-Wide Cross-Sectional Study Tracking In-service Training Clinical Staff.Front Public Health. 2021 Mar 17;9:639273. doi: 10.3389/fpubh.2021.639273. eCollection 2021. Front Public Health. 2021. PMID: 33816424 Free PMC article. Clinical Trial.
-
Association of Self-Reported Dietary and Drug Compliance with Optimal Metabolic Control in Patients with Type 2 Diabetes: Clinic-Based Single-Center Study in a Developing Country.J Nutr Metab. 2018 Jul 24;2018:3421476. doi: 10.1155/2018/3421476. eCollection 2018. J Nutr Metab. 2018. PMID: 30140455 Free PMC article.
-
General characteristics and reasons for the discontinuation of drug clinical trials in mainland China.BMC Med Res Methodol. 2021 Nov 13;21(1):246. doi: 10.1186/s12874-021-01443-2. BMC Med Res Methodol. 2021. PMID: 34773983 Free PMC article.
-
The Status of Metabolic Control in Patients With Type 2 Diabetes Attending Dasman Diabetes Institute, Kuwait.Front Endocrinol (Lausanne). 2019 Jun 26;10:412. doi: 10.3389/fendo.2019.00412. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31297092 Free PMC article.
-
Evidence for validity of a national physician and patient-reported, cross-sectional survey in China and UK: the Disease Specific Programme.BMJ Open. 2016 Aug 16;6(8):e010352. doi: 10.1136/bmjopen-2015-010352. BMJ Open. 2016. PMID: 27531722 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous